Patent Application
20050131475
The invention relates to an electrode configuration for an implantable cardioverter defibrillator, not requiring, however allowing, a defibrillation electrode placed in a ventricle of the heart.
In the prior art (as depicted in
The electrically conductive portion of the can comprise, for example, one or more discrete electrodes such as the apparatus and methods described and depicted in U.S. Pat. No. 6,230,059 to Duffin, assigned to Medtronic, Inc. This patent issued on 8 May 2001 and is entitled, “Implantable Monitor” and sets forth prior art and inventive techniques for collecting physiologic information from a subject via a plurality of subcutaneous and submuscular electrode pairs that define diverse sensing vectors.
In addition, the techniques for discriminating potentially lethal from non-lethal arrhythmias, so as to withhold a high voltage therapy, have been utilized in the art. For example, U.S. Pat. No. 5,545,186 to Olson et al. which is also assigned to Medtronic, Inc. filed on 30 Mar. 1995, issued 13 Aug. 1996 and entitled, “Prioritized Rule Based Method and Apparatus for Diagnosis and Treatment of Arrhythmias” provides one such example known to those of skill in the art to which the invention is directed.
Of course, over the long history of defibrillators used to provide acute therapy (e.g., using temporarily implanted leads and external circuitry) and ambulatory implantable medical devices, such as ICDs, those of skill in the art (e.g., including cardiologists, electrophysiologists, medical doctors, biomedical engineers, medical device specialists—including designers and developers therefor, and the like) appreciate that a vast amount of prior art has been generated as science and medicine continue to advance and converge toward more safe and efficacious methods of providing therapy to terminate potentially lethal episodes of cardiac arrhythmia. The inventor hereof contributes to the advancement and convergence of defibrillation by describing, depicting and claiming the following embodiments and aspects of the subject matter he invented.
The invention provides effective ventricular defibrillation, defibrillation methods and systems that, according to certain embodiments of the invention, do not require direct contact with excitable myocardial tissue. For example, such embodiments only optionally include a defibrillation electrode disposed within, on or about a heart (e.g., devoid of endocardial, epicardial or pericardial electrodes for example disposed in contact with a portion of the SVC, right ventricle or the like. These embodiments are thus relevant to subjects contra-indicated for medical electrical leads disposed in the right atrium (RA) and right ventricle (RV), as is the case for subjects having an artificial right sided atrio-ventricular valve (i.e., tricuspid valve). Also subjects who already have an implanted and operative RA-RV pacing lead can benefit from the teaching of the invention. That is, the existing pacing lead does not need to be removed and may remain functional without requiring placement of a second lead in the RA-RV.
In a prophylactic application, for example to protect a subject from sudden cardiac death, an ICD system according to the invention can be placed completely in the subcutaneous or submuscular position without the need to place leads or electrodes in the cardiovascular system.
Such a system, using a dorsal subcutaneous array electrode instead of a SVC electrode, has been described in computer simulations with the same model as described above. The invention results in a configuration with the least invasive (in vascular terms) approach, which may be beneficial to the patient. The invention may also be applied in situations where the RV defibrillation electrode has become ineffective, by component failure or other cause. In case the RV defibrillation lead is also provided with a SVC defibrillation electrode, the latter may be used in combination with precordial electrode according to this invention. The invention could also be applied when the ICD device cannot be placed in the left subclavicular area. Right sided or abdominal implantation of the Active Can ICD device may result in ineffective defibrillation capacity of the system. Here the use of precordial electrodes and an inactive Can could help.
The inventions solves the problem if, for example during open chest surgery, epicardial defibrillation electrode placement is not feasible because of large size of the electrodes presence of coronary bypasses or other factors that limit or prohibit or render impractical to use either epicardial or endocardial leads. During this procedure smaller pacing and sensing electrodes can be placed and used for pacing and sensing in the defibrillation system.
One set of embodiments of the invention provides a variety of configurations for delivering cardioversion/defibrillation therapy with a vector of energy controlled by operative circuitry of a non-active can, or canister housing, type ICD. The ICD can be conveniently disposed in a surgically created pocket formed in one of a variety of locations of a patient's abdomen, pectoral region, or the like. The ICD electrically couples to one or more high voltage electrodes (e.g., coil type, patch type, array type, etc.) and at least one electrode disposed within a portion of the SVC part of the vasculature of a patient thus providing a number of clinician-selectable defibrillation vectors between the electrodes tailored for the shape, or contour, of a given patient's heart. The one or more high voltage electrode can include a set of coil electrodes disposed in a precordial orientation relative to a patient's heart that provides several different therapy delivery vectors between the SVC electrode and one or more of the precordial coil electrodes.
In another embodiment of the invention, a high voltage (e.g., coil-type) electrode is disposed within a portion of the SVC part of the vasculature of a patient and in electrical communication with an active ICD can disposed in a precordial position. The SVC coil electrode can be disposed in a relatively “high” location relative to the RA of a patient in order to enhance the therapy delivery vector between the SVC coil and the active can of a precordial ICD.
In yet another embodiment of the invention an active canister portion of a precordial ICD couples a therapy delivery vector between or among the active can, an RV coil electrode, and/or an appropriately located SVC electrode (e.g., disposed in a relatively ‘low’ orientation). As in the former and other embodiments, the precordial ICD can be implanted in a subcutaneous or submuscular location in order to enhance the electrically communication between and/or among the subcutaneous or submuscular precordial-oriented ICD canister, the RV coil electrode and/or the SVC electrode coil.
Another embodiment of the present invention includes an active can, or canister housing, of a precordial ICD providing therapy delivery vectors between the precordial ICD, an SVC coil and/or a high voltage electrode coil disposed within a portion of the coronary sinus/coronary vein (CS/CV) of a patient.
In yet another embodiment of the invention, therapy delivery vectors are selected from a precordial active can, or canister housing, of an ICD and a precordial- or subcutaneous-submuscular electrode array of electrodes. The active can ICD electrically couples to at least one discrete coil electrode that forms a part of a dorsal (back) subcutaneous electrode array disposed around a part of the thorax and ribs of a patient.
Another aspect of the invention involves pacing and/or sensing using a precordial electrode, including one or more electrodes disposed inward of a subject's intercoastal thoracic muscles. In related embodiments all the components of a cardiac sensing, pacing and defibrillation system are spaced from the subject's excitable myocardial tissue.
Inherent in such methods, components and systems the invention is typically embodied in a processor-based implantable medical device operated pursuant to instructions stored on computer readable media. The invention thus includes all such media now known and later developed.
The foregoing embodiments of the invention merely introduce the subject matter of the present invention and although each is depicted and described herein other aspects and embodiments of the invention are fully intended to fall within the breadth and scope of the present invention and are expressly covered hereby.
The invention relates to an electrode configuration for an implantable cardioverter defibrillator, not requiring, however allowing, a defibrillation electrode placed in the right ventricle of the heart.
The electrode configuration includes at least one of the following electrodes: a precordial electrode, implanted in the subcutaneous or submuscular tissue in an area in front of the heart on the left side of the chest. Herein the term precordial is intended to have its customary meaning consistent with a definition that includes, without limitation, any position within the margins of the shadow of the left ventricle as can be observed on an antero-posterior chest X-ray. Without limitation, some examples of non-precordial electrode positions include locations within the SVC, any of the coronary sinus and/or coronary venous structures, as well as within a chamber such as the RA or RV. However, according to certain aspects of the invention an SVC electrode (alone as a part of dual defibrillation medical electrical lead) or an electrode disposed partially in the SVC and the RA appears to offer acceptable defibrillation/cardioversion therapy delivery vectors.
The precordial electrode may comprise, without limitation: an active can (conductive portion of a metallic housing of a medical device or ICD); a patch-type electrode (e.g., similar to the types known as epicardial patch electrode); a series of coil- or wire-type electrodes (also known in the art as a “subcutaneous array” or equivalent), characterized by an elongated body with a diameter of preferably less than about three (3) millimeters, which can be tunneled in the subcutaneous or submuscular tissue of a subject; and any combination of the foregoing alternatives.
A reasonable overall set of dimensions for precordial electrodes or combination of electrodes includes approximately six (6) centimeters in the longitudinal (caudal-cranial) direction and about eight (8) centimeters in the lateral direction. Dimensions may of course be varied according to the size of the heart and the thorax, among other factors. Larger electrodes can be utilized and can be expected to result in lower defibrillation shock impedance, which generally leads to lower shock energy, required to defibrillate the heart. The inventor suggests that electrode dimensions exceeding the margins of the heart contour may result in higher defibrillation energy requirement, although still performing according to the teaching of the present invention.
The SVC or RA electrode is preferably placed in a position where the middle part of the electrode is placed at the longitudinal thoracic level of the intersection of the plane formed by the longitudinal axes of the left ventricle and the right ventricle and the elongated center line of the SVC. An effective length of the SVC electrode can be sized with relation to the short axis dimension of the LV, for example, which is typically on the order of about seven (7) to about (10) centimeters.
Pacing and sensing aspects of the invention: Although the design of pacing and sensing electrodes for a precordial defibrillation system is not the primary objective of the invention, pacing and sensing with electrodes specially designed for the precordial system should be considered as part of the invention. Sensing can be done with sensing electrodes incorporated in the precordial active can. Preferably three (3) or four (4) sensing electrodes, with different vectors, should be available in order to be able to select the best combination for detection of ventricular and atrial signals. The selection should be done automatically, because the position and orientation of the can relative to the heart is determined at the time of implant or may change during the period of implantation. In case of precordial coil implantation, the defibrillation coils can be provided with tip or ring electrodes that have sensing performance similar to those of the precordial can.
Stimulation of the heart can be done by the same as the sensing electrodes, which will require more energy than normal pacing electrodes that are implanted inside or directly on the heart. Special electrodes that are pierced through the intercostals muscles and places just outside the pericardium can be used for sensing and pacing at lower energy.
Pacing and sensing can also be performed with any other lead that is permanently implanted. Epicardial electrodes are suitable when placed during an open chest procedure. Endocardial electrodes can also be used. These electrodes may previously have been implanted as part of a pacing or defibrillation system or as part of the configuration described by the invention.
In addition, the electrode configuration may be extended with the use of dorsal electrodes, (in an “array” configuration), preferably with the same polarity as the SVC electrode.
The system using precordial electrodes should have an ICD device with an electrically inactive can or metal housing that could be placed in the subclavicular area or in the abdominal area.
The embodiments of the invention thus described and/or depicted should not be viewed as limiting but rather illustrative of the invention. As those of skill in the art will readily appreciate, variations in components, procedures and steps could be envisaged without departing from the true scope of the invention, which scope is literally defined by the appended claims. The inventor hereby literally claims ownership of all the following structures, methods, systems and computer readable media, including equivalents and insubstantial variations thereof.
The present application is a continuation of utility U.S. patent application Ser. No. 10/360,762, filed Dec. 7, 2001, which is a converted non-provisional of provisional U.S. patent application Ser. No. 60/336,728, filed 7 Dec. 2001, the entire disclosures of which are incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| Parent | 10360762 | Dec 2001 | US |
| Child | 10985341 | Nov 2004 | US |
